LiveCare Inc. Resolves Investigation by U.S. Department of Justice
Venice, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) – LiveCare Inc. (OTCMKTS: LVCE) announced today the resolution of an investigation by the U.S. Department of Justice regarding allegations related to the Anti-Kickback Statute and the False Claims Act. The resolution came as a result of LiveCare’s self-disclosure to the government in July 2023 and the company’s full cooperation with the Department of Justice throughout the investigation.
Background
The investigation by the U.S. Department of Justice into LiveCare Inc. centered around allegations related to violations of the Anti-Kickback Statute and the False Claims Act. The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals or generate federal healthcare program business. The False Claims Act prohibits knowingly submitting false or fraudulent claims for payment to the government.
Resolution
As a result of LiveCare Inc.’s self-disclosure and cooperation with the Department of Justice, the company was able to reach a resolution regarding the investigation. The specifics of the resolution were not disclosed in the announcement, but it is clear that LiveCare took the necessary steps to address any potential wrongdoing and work towards a positive outcome.
Impact on Individuals
For individuals, the resolution of the investigation by the U.S. Department of Justice may bring a sense of reassurance that LiveCare Inc. has taken responsibility for any potential violations and is committed to operating ethically and in compliance with federal healthcare laws. This can be especially important for patients who rely on LiveCare’s services for their healthcare needs.
Global Impact
On a global scale, the resolution of investigations like the one involving LiveCare Inc. can have ripple effects throughout the healthcare industry. It serves as a reminder to companies and healthcare providers around the world of the importance of compliance with regulations and the serious consequences of violating laws such as the Anti-Kickback Statute and the False Claims Act.
Conclusion
In conclusion, the resolution of the investigation by the U.S. Department of Justice is a positive step for LiveCare Inc. as it demonstrates the company’s commitment to accountability and compliance with healthcare laws. The impact of this resolution extends to individuals who rely on LiveCare’s services and serves as a global reminder of the importance of ethical business practices in the healthcare industry.
